ADRs Gain Overall Monday; AstraZeneca's ADRs Weaken After Vaccine News

11/23/2020 | 05:02pm

By Micah Maidenberg

The S&P/BNY Mellon index of American depositary receipts gained 0.9% Monday to 148.89. The European index closed at 121.61, 0.7% higher. The emerging-markets and the Asian indices rose 1.2% and 1.1%, respectively, closing at 392.17 and 221.5. The index for Latin American ADRs increased 1.6% to 392.17.

AstraZeneca PLC's American depositary receipts ended down 1.1%. AstraZeneca and the University of Oxford said Monday their Covid-19 vaccine was effective as much as 90% of the time in preventing infections without major side effects. Moderna Inc. has also developed a vaccine, as have Pfizer Inc. and Germany's BioNTech SE, while China and Russia have deployed their own vaccines to combat Covid-19.

ADRs for gold producers fell in tandem with lower prices for the precious metal on Monday. Gold Fields Ltd. receipts were off almost 5% to $9.17 while Harmony Gold Mining Co.'s dropped 7.3% to $4.32. AngloGold Ashanti Ltd.'s ADR fell 4.7% to $21.51.

Write to Micah Maidenberg at

(END) Dow Jones Newswires

11-23-20 1701ET

Copier lien
Latest news about "Markets"
1d ago
1d ago
1d ago
1d ago
2d ago